Welcome to the Pacific Edge Investor Centre. Here you will find useful information about being a shareholder of our company.
See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up on our share price.
Pacific Edge is a publicy listed company on the NZX: listed as PEB.
- Value $00,000.000
- Volume 00,000
- Capitalisation $000,000
- Open $0.000
- Close $0.000
- High $0.000
- Low $0.000
Data up to date as of 00-00-0000 00:00
Pacific Edge Signs Contract with MediNcrease Health Plan in US
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB), has entered into an agreement with MediNcrease Health Plans, LLC, a national provider network in the United States, to make Cxbladder available to 5.5 million covered lives through its clients and payers. [read more]
Pacific Edge Signs First Commercial Agreement in Singapore
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has reached a commercial agreement with Raffles Diagnostica Pte Ltd to offer its suite of Cxbladder tests in Singapore. [read more]
Reports and Presentations
For further investor information on Pacific Edge our recent annual reports, investor presentations and investment research reports are available for download below
FY17 Full Year Results Conference Call Audio Commentary[5.8 MB]
FY17 Full Year Results Presentation[3.1 MB]